APA (7th ed.) Citation

Wu, J., Liu, T., Shi, S., Fan, Z., Hiram, R., Xiong, F., . . . Huang, C. (2022). Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling. Cardiovascular Diabetology, 21(1), 1. https://doi.org/10.1186/s12933-022-01614-5

Chicago Style (17th ed.) Citation

Wu, Jinchun, et al. "Dapagliflozin Reduces the Vulnerability of Rats with Pulmonary Arterial Hypertension-induced Right Heart Failure to Ventricular Arrhythmia by Restoring Calcium Handling." Cardiovascular Diabetology 21, no. 1 (2022): 1. https://doi.org/10.1186/s12933-022-01614-5.

MLA (9th ed.) Citation

Wu, Jinchun, et al. "Dapagliflozin Reduces the Vulnerability of Rats with Pulmonary Arterial Hypertension-induced Right Heart Failure to Ventricular Arrhythmia by Restoring Calcium Handling." Cardiovascular Diabetology, vol. 21, no. 1, 2022, p. 1, https://doi.org/10.1186/s12933-022-01614-5.